{
  "id": "dnd_ace_inhibitor_hyperkalemia_risk_v2026",
  "type": "dragAndDropCloze",
  "stem": "After reviewing the patient's electronic health record (EHR), including the nurse's notes, vital signs, lab results, and medication administration record (MAR), determine the most appropriate nursing intervention and its primary rationale.",
  "template": "The nurse should {{blank1}} because {{blank2}}.",
  "options": [
    "hold the next dose of lisinopril and notify the provider",
    "encourage increased fluid intake",
    "the patient is at risk for hyperkalemia",
    "monitor the patient's blood pressure more frequently",
    "the patient's potassium level is within normal limits"
  ],
  "blanks": [
    {
      "id": "blank1",
      "correctOption": "hold the next dose of lisinopril and notify the provider"
    },
    {
      "id": "blank2",
      "correctOption": "the patient is at risk for hyperkalemia"
    }
  ],
  "itemContext": {
    "tabs": [
      {
        "id": "sbar",
        "title": "Nurses' Notes",
        "content": "07:00 Patient reports feeling weak and slightly dizzy. Denies chest pain or shortness of breath. Noted slight muscle cramping in lower extremities. Alert and oriented x3. Skin warm and dry, no edema noted. 09:00 Patient reports persistent weakness. Potassium level resulted as 5.8 mEq/L. Notified provider of lab value. Will continue to monitor patient. 11:00 Patient resting comfortably. Vital signs stable. Awaiting provider orders. Encouraged patient to avoid high potassium foods. Educated patient about potential side effects of lisinopril, including hyperkalemia, and the importance of regular lab monitoring. Patient verbalized understanding. 13:00 Provider order received to hold lisinopril and repeat potassium level in 4 hours."
      },
      {
        "id": "vitals",
        "title": "Vital Signs",
        "content": "<table><thead><tr><th>Time</th><th>BP</th><th>HR</th><th>RR</th><th>SpO2</th></tr></thead><tbody><tr><td>07:00</td><td>130/80</td><td>72</td><td>16</td><td>98%</td></tr><tr><td>09:00</td><td>128/78</td><td>74</td><td>16</td><td>99%</td></tr><tr><td>11:00</td><td>132/82</td><td>70</td><td>18</td><td>98%</td></tr></tbody></table>"
      },
      {
        "id": "labs",
        "title": "Lab Results",
        "content": "<table><thead><tr><th>Lab</th><th>Result</th><th>Normal Range</th></tr></thead><tbody><tr><td>Potassium</td><td>5.8 mEq/L</td><td>3.5-5.0 mEq/L</td></tr><tr><td>Sodium</td><td>140 mEq/L</td><td>135-145 mEq/L</td></tr><tr><td>BUN</td><td>20 mg/dL</td><td>10-20 mg/dL</td></tr><tr><td>Creatinine</td><td>1.2 mg/dL</td><td>0.6-1.2 mg/dL</td></tr></tbody></table>"
      },
      {
        "id": "exam",
        "title": "Physical Exam",
        "content": "General: Patient alert and oriented x3. Appears slightly weak. Cardiovascular: Regular heart rate and rhythm, no murmurs noted. Respiratory: Clear lung sounds bilaterally. Neurological: Gross motor strength intact, slight muscle cramping in lower extremities. Skin: Warm and dry, no edema noted."
      },
      {
        "id": "orders",
        "title": "Care Plan",
        "content": "<ul><li>Monitor potassium levels every 4 hours.</li><li>Assess for signs and symptoms of hyperkalemia.</li><li>Administer medications as prescribed.</li><li>Educate patient on low-potassium diet.</li></ul>"
      },
      {
        "id": "mar",
        "title": "MAR",
        "content": "<table><thead><tr><th>Medication</th><th>Dosage</th><th>Route</th><th>Frequency</th><th>Last Administered</th></tr></thead><tbody><tr><td>Lisinopril</td><td>20 mg</td><td>PO</td><td>Daily</td><td>06:00</td></tr></tbody></table>"
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "analyze",
    "cjmmStep": "takeAction",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 4,
    "topicTags": [
      "ACE Inhibitor Hyperkalemia Risk"
    ]
  },
  "rationale": {
    "correct": "The patient's elevated potassium level (5.8 mEq/L) indicates hyperkalemia, a known side effect of ACE inhibitors like lisinopril. Holding the medication and notifying the provider is the most appropriate action to prevent further increases in potassium and potential complications.",
    "incorrect": "Incorrect options do not address the immediate risk posed by the elevated potassium level or are not directly related to the patient's current condition.",
    "answerBreakdown": [
      {
        "label": "Blank 1",
        "content": "Holding the lisinopril dose is crucial because ACE inhibitors can increase potassium levels by reducing aldosterone production, which normally promotes potassium excretion. Notifying the provider ensures timely evaluation and potential adjustments to the patient's medication regimen.",
        "isCorrect": true
      },
      {
        "label": "Blank 2",
        "content": "Hyperkalemia can lead to cardiac arrhythmias and muscle weakness. Addressing this electrolyte imbalance is the priority to prevent potentially life-threatening complications.",
        "isCorrect": true
      }
    ],
    "clinicalPearls": [
      "ACE inhibitors can cause hyperkalemia, especially in patients with renal impairment or those taking other medications that affect potassium levels.",
      "Regular monitoring of potassium levels is essential for patients taking ACE inhibitors.",
      "Signs and symptoms of hyperkalemia include muscle weakness, fatigue, and cardiac arrhythmias."
    ],
    "questionTrap": {
      "trap": "Students may be tempted to monitor blood pressure more frequently due to lisinopril's hypotensive effects, but the immediate concern is the elevated potassium.",
      "howToOvercome": "Prioritize interventions based on the most critical and life-threatening findings. In this case, the elevated potassium level takes precedence over blood pressure monitoring."
    },
    "mnemonic": {
      "title": "ACE Inhibitors and Potassium",
      "expansion": "ACE: Assess Potassium, Control Electrolytes"
    }
  },
  "scoring": {
    "method": "polytomous",
    "maxPoints": 2
  },
  "sentinelStatus": "healed_v2026_v11"
}